Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Ther
Autors principals: Evans, Marc, Dejager, Sylvie, Schweizer, Anja, Foley, James E.
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2015
Matèries:
Commentary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4374076/
https://ncbi.nlm.nih.gov/pubmed/25783754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-015-0104-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars